Nrf2 prevents diabetic cardiomyopathy via antioxidant effect and normalization of glucose and lipid metabolism in the heart
Journal of Cellular Physiology · 2024-02 · 239 (2)
DOI: 10.1002/jcp.31149 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular Physiology, online erschienen am 03.02.2024. Verfasst von Ge Yang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Pathobiology, Ministry of Education, College of Basic Medical Sciences, Jilin University, Changchun, Jilin, China. Hauptthemen laut MEDLINE: Diabetic Cardiomyopathies, Diabetes Mellitus, Experimental. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 84 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Jilin Provincial Science and Technology Foundations, Chang chun science and technology bureau development plan project.
Abstract (Originalsprache)
Metabolic disorders and oxidative stress are the main causes of diabetic cardiomyopathy. Activation of nuclear factor erythroid 2‐related factor 2 (Nrf2) exerts a powerful antioxidant effect and prevents the progression of diabetic cardiomyopathy. However, the mechanism of its cardiac protection and direct action on cardiomyocytes are not well understood. Here, we investigated in a cardiomyocyte‐restricted Nrf2 transgenic mice (Nrf2‐TG) the direct effect of Nrf2 on cardiomyocytes in DCM and its mechanism. In this study, cardiomyocyte‐restricted Nrf2 transgenic mice (Nrf2‐TG) were used to directly observe whether cardiomyocyte‐specific overexpression of Nrf2 can prevent diabetic cardiomyopathy and correct glucose and lipid metabolism disorders in the heart. Compared to wild‐type mice, Nrf2‐TG mice showed resistance to diabetic cardiomyopathy in a streptozotocin‐induced type 1 diabetes mouse model. This was primarily manifested as improved echocardiography results as well as reduced myocardial fibrosis, cardiac inflammation, and oxidative stress. These results showed that Nrf2 can directly act on cardiomyocytes to exert a cardioprotective role. Mechanistically, the cardioprotective effects of Nrf2 depend on its antioxidation activity, partially through improving glucose and lipid metabolism by directly targeting lipid metabolic pathway of AMPK/Sirt1/PGC‐1α activation via upstream genes of sestrin2 and LKB1, and indirectly enabling AKT/GSK‐3β/HK‐Ⅱ activity via AMPK mediated p70S6K inhibition.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Pathobiology, Ministry of Education, College of Basic Medical Sciences, Jilin University, Changchun, Jilin, China.
- Jilin Provincial Key Laboratory of Radiation Oncology & Therapy, The First Hospital of Jilin University, and Key Laboratory of Pathobiology, Ministry of Education, Jilin University, Changchun, Jilin, China.
- Department of Radiation Oncology, The First Hospital of Jilin University, Changchun, Jilin, China.
- NHC Key Laboratory of Radiobiology, School of Public Health, Jilin University, Changchun, Jilin, China.
ORCID-Profile: Ying Xin
Förderung
- National Natural Science Foundation of China
- Jilin Provincial Science and Technology Foundations
- Chang chun science and technology bureau development plan project
Zitieren
APA
Yang, G., Zhang, Q., Dong, C., Hou, G., Li, J., Jiang, X., & Xin, Y. (2024). Nrf2 prevents diabetic cardiomyopathy via antioxidant effect and normalization of glucose and lipid metabolism in the heart. Journal of Cellular Physiology, 239(2). https://doi.org/10.1002/jcp.31149
Vancouver
Yang G, Zhang Q, Dong C, Hou G, Li J, Jiang X, et al. Nrf2 prevents diabetic cardiomyopathy via antioxidant effect and normalization of glucose and lipid metabolism in the heart. Journal of Cellular Physiology. 2024;239(2). doi:10.1002/jcp.31149
BibTeX
@article{Yang2024,
author = {Yang, Ge and Zhang, Qihe and Dong, Chao and Hou, Guowen and Li, Jinjie and Jiang, Xin and Xin, Ying},
title = {Nrf2 prevents diabetic cardiomyopathy via antioxidant effect and normalization of glucose and lipid metabolism in the heart},
journal = {Journal of Cellular Physiology},
year = {2024},
volume = {239},
number = {2},
doi = {10.1002/jcp.31149}
}
EUVIMED